Abstract
This study was conducted between September 2012 and May 2013 in three Districts of Borana pastoral area to determine seroprevalence of contagious caprine pleuropneumonia (CCPP) and assess field performance of inactivated commercial vaccine, produced by the National Veterinary Institute (NVI) in Ethiopia, against CCPP. Both pre and post vaccination sera samples were tested using competitive enzyme linked immunosorbent assay (cELISA). Out of 510 examined sera, 161 samples were positive for CCPP, giving an overall seroprevalence of 31.6% (95% CI = 27.57-35.64%) in the study area. Seroprevalence of 35.2, 35.1 and 25% were recorded in Arero, Dhas and Yabello districts, respectively. However, there was no significant difference (χ2=5.56, P=0.062) in seropositivity among the three districts and between male and female goats (χ2=0.068, P=0.794) examined in this study. On the other hand, the differences in seroprevalence among the age categories were statistically significant (χ2=24.48, p<0.0001). A rise in antibody (seroconversion) was observed after field vaccination of goats with inactivated CCPP vaccine and a total of 253 of the 414 examined sera samples were positive for Mycoplasma capricolum subsp. capripneumoniae (Mccp) specific antibodies, thus 61.1% of goats seroconverted following vaccination. Comparison of Mccp specific antibodies in the goat population before and after vaccination indicated that the number of positive reactors increased significantly (P<0.0001) following CCPP vaccination. Seropositivity following vaccination was analyzed among the three age groups and statistically significant differences (χ2=45.48, P<0.0001) were recorded. The change in the serum antibody after vaccination was found to be higher in younger and adult aged goats than old aged goats. In conclusion, the present study indicates that CCPP is one of the major goat health problems in Borana pastoral area which warrants appropriate measures to be in place towards the prevention and control of the disease. Moreover, field vaccination of goats by inactivated CCPP vaccine induced seropositivity in majority of the inoculated goats. Future controlled experimental studies with challenge infection after vaccination need to be conducted for further evaluation of the vaccine efficacy. Key words: Borana pastoral area, contagious caprine pleuropneumonia (CCPP), goats, inactivated vaccine, seroconversion, seroprevalence.
Highlights
Ethiopia possesses an estimated 22.6 million heads of goats (CSA, 2012)
Contagious caprine pleuropneumonia (CCPP) is one of the most important infectious diseases of goats that pose a significant threat to production capacities of this animal
It is a highly contagious and severe respiratory disease caused by Mycoplasma capricolum subspecies capripneumoniae (Mccp) (OIE, 2008)
Summary
Ethiopia possesses an estimated 22.6 million heads of goats (CSA, 2012). goats represent a great national resource, their productivity is sub-optimal.Among the several factors that hamper the productivity of this animal, diseases take a lion share. Ethiopia possesses an estimated 22.6 million heads of goats (CSA, 2012). Goats represent a great national resource, their productivity is sub-optimal. Among the several factors that hamper the productivity of this animal, diseases take a lion share. Contagious caprine pleuropneumonia (CCPP) is one of the most important infectious diseases of goats that pose a significant threat to production capacities of this animal. It is a highly contagious and severe respiratory disease caused by Mycoplasma capricolum subspecies capripneumoniae (Mccp) (OIE, 2008). The presence of CCPP in Ethiopia had been suspected since 1983 and was confirmed later in 1990 by isolation and identification of Mccp following an outbreak of CCPP in Ogaden, Eastern Ethiopia (Thiaucourt et al, 1992)
Sign-in/Register to view highlights & summary Sign-in/Register to access full text options 
Free) 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a call
